Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2022 Earnings Conference Call July 27, 2022 8:30 AM ET

Company Participants

Chris Ward - Senior Director, Investor Relations

Jan De Witte - President & Chief Executive Officer

Glenn Coleman - Chief Operating Officer

Carrie Anderson - Chief Financial Officer

Conference Call Participants

Steve Lichtman - Oppenheimer

Vik Chopra - Wells Fargo

Ryan Zimmerman - BTIG

Joanne Wuensch - Citi

Sam Brodovsky - Truist

Matt Miksic - Barclays

Craig Bijou - Bank of America

Jayson Bedford - Raymond James

Drew Ranieri - Morgan Stanley

Operator

Good day, and welcome to the Integra LifeSciences Second Quarter 2022 Financial Results Conference Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Chris Ward, Senior Director, Investor Relations. Please go ahead, sir.

Chris Ward

Thank you, Leanne. Good morning and thank you for joining the Integra LifeSciences second quarter 2022 earnings conference call. Joining me on the call this morning are Jan De Witte, President and Chief Executive Officer; Glenn Coleman, Chief Operating Officer; and Carrie Anderson, Chief Financial Officer.

Earlier today, we issued a press release announcing our second quarter 2022 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors, Events & Presentations and the file named Second Quarter 2022 Earnings Call Presentation.

Before we begin, I would like to remind you that many of the statements made during this call may be considered forward-looking statements. Factors that could cause actual results to differ materially are discussed in the Company' Exchange Act Report filed with the SEC and in the release.

Also, in our prepared remarks, we'll make reference to both reported and organic revenue growth. Organic revenue growth excludes the effects of foreign currency; acquisitions, including ACell for the first 19 days of the year, divestitures, as well as discontinued products. Unless otherwise stated, all disaggregated and franchise-level revenue growth rates are based on organic performance.

And lastly, our comments today will include certain non-GAAP financial measures. Reconciliations of any non-GAAP financial measures can be found in today's press release, which is an exhibit to Integra's current report on Form 8-K filed today with the SEC.

And with that, I will now turn the call over to Jan.

Jan De Witte

Thank you, Chris. And good morning, everyone. Let me start by reviewing our second quarter and first half business highlights on slide four. To summarize our performance over the past six months, we started the year strongly with the second quarter building nicely off our first quarter momentum.